Amgen

AMG 714 Expanded Access Program

Brief Summary: 
Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.
Available
EA Type
Individual Patients
Celiac Disease

Biological: AMG 714

Eligibility Criteria: 

Inclusion Criteria:

-

Exclusion Criteria:

-

Eligibility Gender: 
All
Eligibility Age: 
Minimum: 18 Years
Contacts: 

Amgen Call Center
866-572-6436
medinfo@amgen.com

EA Number: 
Keywords: 
Refractory Celiac Disease Type II
MeSH Terms: 
Celiac Disease
Disclaimer:
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.